CLG
Collplant
Stock
Stock
ISIN: IL0004960188
Ticker: CLGN
IL0004960188
CLGN
Price
Price
CHART BY
Frequently asked questions
What is Collplant's market capitalization?
The market capitalization of Collplant is $40.89M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Collplant?
Collplant's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.521. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Collplant's stock?
Currently, 1 analysts cover Collplant's stock, with a consensus target price of $14.00. Analyst ratings provide insights into the stock's expected performance.
What is Collplant's revenue over the trailing twelve months?
Over the trailing twelve months, Collplant reported a revenue of $650.00K.
What is the EBITDA for Collplant?
Collplant's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$17.27M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Collplant?
Collplant has a free cash flow of -$13.49M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Collplant have, and what sector and industry does it belong to?
Collplant employs approximately 75 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Collplant's shares?
The free float of Collplant is 7.88M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $40.89M
- EPS (TTM)
- -$1.521
- Free Float
- 7.88M
- Revenue (TTM)
- $650.00K
- EBITDA (TTM)
- -$17.27M
- Free Cashflow (TTM)
- -$13.49M
Pricing
- 52W span
- $3.25$6.75
Analyst Ratings
The price target is $14.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
- Employees
- 75
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- IL0004960188
- Primary Ticker
- CLGN